title: [Autologous transfusion: when best should not be the enemy of good enough...].
abstract: Autologous blood transfusion has been shown to decrease allogeneic transfusion in patients undergoing elective procedures, in adults as well as in children. However, its indication must be carefully discussed for each patient, since, on the one hand, viral risks associated with allogeneic blood are greatly reduced, while on the other hand, adverse events may occur in some patients with poor physical condition. An assessment of the ratio 'benefit-risk' has to be made for each patient.
authors.forename: M
authors.initials: M
authors.lastname: de Montalembert
mesh_terms: D000328:Adult; D001781:Blood Component Removal; D001789:Blood Group Antigens; D001804:Blood Transfusion, Autologous / Q000009:adverse effects / Q000592:standards*; D003141:Communicable Diseases / Q000097:blood / Q000635:transmission; D004912:Erythrocytes / Q000276:immunology; D006801:Humans; D017053:Infection Control; D007518:Isoantibodies / Q000097:blood; D018570:Risk Assessment; D012449:Safety; D065227:Transfusion Reaction
chemical_list: D001789:Blood Group Antigens; D007518:Isoantibodies